Elevai Labs Inkomsten in het verleden
Verleden criteriumcontroles 0/6
Elevai Labs's earnings have been declining at an average annual rate of -49.5%, while the Personal Products industry saw earnings growing at 11.7% annually. Revenues have been growing at an average rate of 140% per year.
Belangrijke informatie
-49.5%
Groei van de winst
-39.9%
Groei van de winst per aandeel
| Personal Products Groei van de industrie | 20.9% |
| Inkomstengroei | 140.0% |
| Rendement op eigen vermogen | -180.0% |
| Nettomarge | -192.1% |
| Laatste winstupdate | 30 Jun 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Opbrengsten en kosten
Hoe Elevai Labs geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 24 | 2 | -5 | 6 | 0 |
| 31 Mar 24 | 2 | -5 | 5 | 0 |
| 31 Dec 23 | 2 | -4 | 4 | 0 |
| 30 Sep 23 | 1 | -4 | 4 | 0 |
| 30 Jun 23 | 1 | -4 | 3 | 0 |
| 31 Mar 23 | 1 | -3 | 2 | 0 |
| 31 Dec 22 | 1 | -2 | 2 | 0 |
| 31 Dec 21 | 0 | -1 | 1 | 0 |
Kwaliteitswinsten: ELAB is currently unprofitable.
Groeiende winstmarge: ELAB is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: ELAB is unprofitable, and losses have increased over the past 5 years at a rate of 49.5% per year.
Versnelling van de groei: Unable to compare ELAB's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: ELAB is unprofitable, making it difficult to compare its past year earnings growth to the Personal Products industry (22.2%).
Rendement op eigen vermogen
Hoge ROE: ELAB has a negative Return on Equity (-179.98%), as it is currently unprofitable.